Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847248 | PMC |
http://dx.doi.org/10.1080/09546634.2021.1937484 | DOI Listing |
Background: Hidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist.
Objective: To provide evidence-based consensus recommendations for patients with HS in seven special patient populations: i) pregnancy, ii) breastfeeding, iii) pediatrics, iv) malignancy, v) tuberculosis infection, vi) hepatitis B or C infection, and vii) HIV disease.
Br J Surg
November 2024
Department of Surgery, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Postepy Dermatol Alergol
October 2024
Department of Dermatology, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland.
Introduction: Hidradenitis suppurativa is a chronic, recurring skin condition characterized by inflammation of the terminal hair follicle. It presents as painful, deep-seated, inflamed lesions such as nodules, fistulas, and abscesses. While the mean onset age for hidradenitis suppurativa is typically between 21 and 29 years, the condition can also manifest in childhood.
View Article and Find Full Text PDFJ Am Acad Dermatol
November 2024
Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Electronic address:
J Eur Acad Dermatol Venereol
November 2024
Division of Dermatology and Venereology, University Hospitals of Geneva, Geneva, Switzerland.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!